Ardent Health (ARDT) Cash from Financing Activities (2023 - 2026)

Ardent Health has reported Cash from Financing Activities for 4 years, with the latest figure at -$11.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 14.79% year-over-year to -$11.8 million; the trailing twelve-month figure through Mar 2026 stood at -$101.4 million (down 446.21% YoY), and the FY2025 full-year result was -$103.5 million, down 519.87% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$11.8 million, up from -$37.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $183.4 million in Q3 2024, with the low at -$119.8 million in Q2 2024.
• Average Cash from Financing Activities over 4 years is -$12.0 million, with a median of -$20.5 million recorded in 2024.
• Year-over-year, Cash from Financing Activities soared 867.13% in 2024 and plunged 114.68% in 2025.
• Tracing ARDT's Cash from Financing Activities over 4 years: stood at -$17.9 million in 2023, then decreased by 14.48% to -$20.5 million in 2024, then sank by 80.88% to -$37.0 million in 2025, then surged by 68.19% to -$11.8 million in 2026.
• The last three Cash from Financing Activities figures came in at -$11.8 million (Q1 2026), -$37.0 million (Q4 2025), and -$26.9 million (Q3 2025), per Business Quant data.

Peer Comparison